Biogen Suffers Yet Another Setback as an Appeal for the Tecfidera Patent is Denied.
Summary: In a split decision, the U.S. Court of Appeals for the Federal Circuit affirmed a West Virginia federal court’s ruling that…
Summary: In a split decision, the U.S. Court of Appeals for the Federal Circuit affirmed a West Virginia federal court’s ruling that…
Synopsis: The FDA granted orphan drug designation to GC012F, a novel chimeric antigen receptor T-cell therapy for the treatment of relapsed or…
SYNOPSIS: VUMERITY is a next-generation oral fumarate treatment for people with relapsing-remitting MS with established efficacy and well-characterized safety, building on Biogen’s…
Secarna to receive an upfront along with an option exercise fees & is also eligible to receive development & commercial milestone along…
KEY POINTS: The U.S. Food and Drug Administration (FDA) has approved the Company’s supplemental New Drug Application (sNDA) for Purified Cortrophin™ Gel…
Keypoints Albaugh announced the EPA registration of Anchor™ 3L ST in multiple crop segments as a new fungicide seed treatment offer. Anchor™…
Keypoints Dr. Reddy’s Laboratories said it has received approval from the US health regulator to market Lenalidomide capsules, used to treat multiple…